These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 14986158

  • 1. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia.
    Fätkenheuer G, Preuss M, Salzberger B, Schmeisser N, Cornely OA, Wisplinghoff H, Seifert H.
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):157-62. PubMed ID: 14986158
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L, Andersen CØ, Frimodt-Møller N, Knudsen IJD, Lundgren J, Benfield TL.
    Trials; 2019 May 02; 20(1):250. PubMed ID: 31046810
    [Abstract] [Full Text] [Related]

  • 3. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis.
    Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, Ichiyama S.
    Infection; 2017 Feb 02; 45(1):83-91. PubMed ID: 27709434
    [Abstract] [Full Text] [Related]

  • 4. Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study.
    Verhagen DW, van der Meer JT, Hamming T, de Jong MD, Speelman P.
    Scand J Infect Dis; 2003 Feb 02; 35(8):459-63. PubMed ID: 14514144
    [Abstract] [Full Text] [Related]

  • 5. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC, Richey MM, Platts-Mills JA, Mathers AJ, Novicoff WM, Cox HL.
    Clin Infect Dis; 2018 Jan 06; 66(1):64-71. PubMed ID: 29020181
    [Abstract] [Full Text] [Related]

  • 6. Community-acquired Staphylococcus aureus bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure.
    Smit J.
    Dan Med J; 2017 May 06; 64(5):. PubMed ID: 28552097
    [Abstract] [Full Text] [Related]

  • 7. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H, Wisplinghoff H, Kaasch A, Achilles K, Langhorst A, Peyerl-Hoffmann G, Woehrmann A, Fätkenheuer G, Salzberger B, Kern WV.
    Dtsch Med Wochenschr; 2008 Feb 06; 133(8):340-5. PubMed ID: 18270913
    [Abstract] [Full Text] [Related]

  • 8. Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?
    Pigrau C, Rodríguez D, Planes AM, Almirante B, Larrosa N, Ribera E, Gavaldà J, Pahissa A.
    Eur J Clin Microbiol Infect Dis; 2003 Dec 06; 22(12):713-9. PubMed ID: 14605943
    [Abstract] [Full Text] [Related]

  • 9. Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
    Rosa R, Wawrzyniak A, Sfeir M, Smith L, Abbo LM.
    J Hosp Med; 2016 Jan 06; 11(1):27-32. PubMed ID: 26381394
    [Abstract] [Full Text] [Related]

  • 10. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L, Harris MT, Brooks A, Main C, Mertz D.
    BMC Infect Dis; 2015 Dec 15; 15():568. PubMed ID: 26666459
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM, Clemenzi-Allen A, Gahbauer A, Deck D, Imp B, Vittinghoff E, Chambers HF, Doernberg S.
    Antimicrob Agents Chemother; 2016 Sep 15; 60(9):5276-84. PubMed ID: 27324762
    [Abstract] [Full Text] [Related]

  • 12. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
    Asgeirsson H, Kristjansson M, Kristinsson KG, Gudlaugsson O.
    J Infect; 2011 May 15; 62(5):339-46. PubMed ID: 21402101
    [Abstract] [Full Text] [Related]

  • 13. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
    Kaasch AJ, Fätkenheuer G, Prinz-Langenohl R, Paulus U, Hellmich M, Weiß V, Jung N, Rieg S, Kern WV, Seifert H, SABATO trial group (with linked authorship to the individuals in the Acknowledgements section).
    Trials; 2015 Oct 09; 16():450. PubMed ID: 26452342
    [Abstract] [Full Text] [Related]

  • 14. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia.
    López-Cortés LE, Del Toro MD, Gálvez-Acebal J, Bereciartua-Bastarrica E, Fariñas MC, Sanz-Franco M, Natera C, Corzo JE, Lomas JM, Pasquau J, Del Arco A, Martínez MP, Romero A, Muniain MA, de Cueto M, Pascual A, Rodríguez-Baño J, REIPI/SAB group.
    Clin Infect Dis; 2013 Nov 09; 57(9):1225-33. PubMed ID: 23929889
    [Abstract] [Full Text] [Related]

  • 15. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
    Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, Meyer P, Christmann D.
    Infect Control Hosp Epidemiol; 2003 Dec 09; 24(12):890-6. PubMed ID: 14700403
    [Abstract] [Full Text] [Related]

  • 16. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
    Forsblom E, Ruotsalainen E, Mölkänen T, Ollgren J, Lyytikäinen O, Järvinen A.
    J Hosp Infect; 2011 Jun 09; 78(2):102-7. PubMed ID: 21511366
    [Abstract] [Full Text] [Related]

  • 17. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases.
    Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N.
    Arch Intern Med; 2002 Jan 14; 162(1):25-32. PubMed ID: 11784216
    [Abstract] [Full Text] [Related]

  • 18. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
    Hounsom L, Grayson K, Melzer M.
    Postgrad Med J; 2011 Nov 14; 87(1033):757-62. PubMed ID: 21798969
    [Abstract] [Full Text] [Related]

  • 19. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW.
    Clin Infect Dis; 2003 Sep 15; 37(6):794-9. PubMed ID: 12955640
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M, Shenone E, Pascale GD, Molinari MP, Cauda R, Viscoli C, Tumbarello M.
    Clin Microbiol Infect; 2012 Sep 15; 18(9):862-9. PubMed ID: 21999245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.